AMIVANTAMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

AMIVANTAMAB

Official Name

English

JNJ-61186372

Preferred Name

English

IMMUNOGLOBULIN G1 (413-LYSINE), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN MONOCLONAL JNJ-61186372 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JNJ-61186372 .KAPPA.-CHAIN, (234->228'),(237->231')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (411-A

Common Name

English

Amivantamab [WHO-DD]

Common Name

English

CNTO-4424

Code

English

AMIVANTAMAB [JAN]

Common Name

English

amivantamab [INN]

Common Name

English

ANTI-EGFR/C-MET BISPECIFIC ANTIBODY JNJ-61186372

Common Name

English

JNJ-611

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C1454

Created by admin on Tue Apr 01 21:18:52 GMT 2025 , Edited by admin on Tue Apr 01 21:18:52 GMT 2025

Code System Code Type Description

FDA UNII

0JSR7Z0NB6

Created by admin on Tue Apr 01 21:18:52 GMT 2025 , Edited by admin on Tue Apr 01 21:18:52 GMT 2025

PRIMARY

NCI_THESAURUS

C124993

Created by admin on Tue Apr 01 21:18:52 GMT 2025 , Edited by admin on Tue Apr 01 21:18:52 GMT 2025

PRIMARY

SMS_ID

100000177630

Created by admin on Tue Apr 01 21:18:52 GMT 2025 , Edited by admin on Tue Apr 01 21:18:52 GMT 2025

PRIMARY

WIKIPEDIA

Amivantamab

Created by admin on Tue Apr 01 21:18:52 GMT 2025 , Edited by admin on Tue Apr 01 21:18:52 GMT 2025

PRIMARY

RXCUI

2549199

Created by admin on Tue Apr 01 21:18:52 GMT 2025 , Edited by admin on Tue Apr 01 21:18:52 GMT 2025

PRIMARY

DAILYMED

0JSR7Z0NB6

Created by admin on Tue Apr 01 21:18:52 GMT 2025 , Edited by admin on Tue Apr 01 21:18:52 GMT 2025

PRIMARY

INN

11030

Created by admin on Tue Apr 01 21:18:52 GMT 2025 , Edited by admin on Tue Apr 01 21:18:52 GMT 2025

PRIMARY

CAS

2171511-58-1

Created by admin on Tue Apr 01 21:18:52 GMT 2025 , Edited by admin on Tue Apr 01 21:18:52 GMT 2025

PRIMARY

ACTIVE MOIETY


					0JSR7Z0NB6